UNSPSC 51282918: Fleroxacin

This classification denotes a quinolone antibiotic with the molecular formula C17H18F3N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N804LDH51K, chemically known as 6,8-difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methylpiperazino)-4-oxo-3-quinolinecarboxylic acid but generally known as fleroxacin, which bears US NIH Compound Identifier 3357. European Medicines Agency schedules Fleroxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07639MIG.

UNSPSC 51282918 Fleroxacin, a Commodity code, shows minimal direct alignment with recent state and local procurement activity. The code nominally describes a specific antibiotic pharmaceutical, but the recent opportunities posted under this code — naloxone procurement, direct-to-manufacturer prescription programs, medical and first aid supplies, and generic multi-source pharmaceuticals — involve different drug products and broader pharmacy benefit management or emergency medical supply sourcing, not fleroxacin specifically. State and local governments do purchase pharmaceuticals through cooperative purchasing vehicles and competitive bidding, but the tagged opportunities under this code do not reflect demand for fleroxacin in particular.

Recent activity spans multiple issuing bodies: Seminole County, Florida (health department supplies); the Texas Health and Human Services Commission (pharmacy benefit program design); the City of Tampa (emergency medical supplies for fire rescue); and the Minnesota Multistate Cooperative Purchasing Alliance (multi-state generic pharmaceutical and OTC contracts). The Minnesota MMCAP RFP, due March 26, 2026, represents the largest and most systematic pharmaceutical procurement identified, serving state and local health systems across Minnesota and Oregon through three authorized wholesalers, with pricing weighted heavily on competitiveness (75 percent) and compliance with cGMP and Drug Supply Chain Security Act standards. The Seminole County naloxone IFB, due July 26, 2023, sought 1,900 units annually with quarterly deliveries, estimated at $700,000 for the Tampa fire medical supplies bid. These opportunities indicate state and local governments source pharmaceuticals, but the code's nominal specificity to fleroxacin does not match the actual recent buying patterns in the tagged records, suggesting either a tagging error or minimal recent fleroxacin procurement activity through state and local channels.